Skip to main content
NATURECELL CO.,LTD. logo

NATURECELL CO.,LTD. — Investor Relations & Filings

Ticker · 007390 ISIN · KR7007390008 KO Manufacturing
Filings indexed 273 across all filing types
Latest filing 2025-02-03 Earnings Release
Country KR South Korea
Listing KO 007390

About NATURECELL CO.,LTD.

http://en.naturecell.co.kr/

NATURECELL CO.,LTD. is a diversified company operating across the food, beverage, cosmetics, and biotechnology sectors. The company manufactures and sells a range of products including canned goods, health functional foods, and fruit juices. In addition to its consumer goods, NATURECELL has a significant focus on its high-tech biotechnology division, which is dedicated to stem cell research and development. This division conducts clinical trials for potential therapeutic applications, with a noted emphasis on treatments for degenerative diseases such as Alzheimer's.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from NatureCell regarding a significant change (over 30%) in revenue or profit/loss structure. It provides a summary table of financial performance (revenue, operating profit, net income) comparing the current fiscal year to the previous one, along with the primary reasons for the change. This is a standard 'Earnings Release' (ER) type disclosure in the Korean market (DART system), providing key financial highlights before the final audited annual report is finalized. FY 2024
2025-02-03 Korean
기타경영사항(자율공시) (특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from NatureCell regarding the acquisition of a patent for stem cell cryopreservation technology. It is categorized as a 'voluntary disclosure' (자율공시) under Korean regulatory standards. Since it does not fit into specific categories like M&A, financial reports, or director dealings, and is a standard regulatory announcement of a corporate event, it falls under the 'Regulatory Filings' (RNS) category.
2024-12-30 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the company's representative director (CEO). It details the previous and current representatives, the reason for the change (resignation), and the effective date. This falls directly under the category of board or management changes.
2024-12-30 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement from Nature Cell regarding the setting of a record date and shareholder register closure period for the purpose of holding an upcoming Annual General Meeting (AGM). Since it is a brief regulatory notice announcing a procedural step for a meeting rather than the meeting materials themselves or a full report, it falls under the general regulatory filing category.
2024-12-13 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for NatureCell, covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial data, business operations, capital structure, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-11 Korean
[기재정정]투자판단관련주요경영사항 (중증퇴행성관절염 줄기세포치료제 조인트스템 미국 FDA 제2b/3a상 임상시험의 실시기관 추가(다국가 임상)을 위한 대한민국 내 임상시험계획 승인)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from NatureCell regarding a clinical trial update for their stem cell therapy, 'JointStem'. It is a 'Correction Report' (정정신고) detailing the approval of a clinical trial plan by the Ministry of Food and Drug Safety in South Korea. Since this is a specific regulatory announcement regarding clinical trial status and does not fit into categories like financial reports, dividends, or M&A, it is classified as a Regulatory Filing (RNS).
2024-10-02 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.